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Although most colorectal cancer develops based on the adenoma–adenocarcinoma sequence, morphologically, colorectal
cancer is not a homogeneous disease entity. Generally, there are two distinct morphological types: polypoid and ulcerative
colorectal tumours. Previous studies have demonstrated that K-ras codon 12 mutations are preferentially associated with
polypoid growth of colorectal cancer; however, little is known about the molecular mechanism that determines ulcerative
growth of colorectal cancer. b-catenin complex plays a critical role both in tumorigenesis and morphogenesis. We examined
the differential expression of b-catenin and its related factors among different types of colorectal cancer in order to determine
any relationship with gross tumour morphology. Immunohistochemical staining of b-catenin, E-cadherin and MMP-7 was
performed on 51 tumours, including 26 polypoid tumours and 25 ulcerative tumours. Protein truncation tests and single-strand
conformational polymorphism for mutation of the adenomatous polyposis coli tumour suppressor gene, as well as single-
strand conformational polymorphism for the mutation of b-catenin exon 3 were also done. Nuclear expression of b-catenin
was observed in 18 out of 25 (72%) cases of ulcerative colorectal cancer and seven out of 26 (26.9%) cases of polypoid
colorectal cancer. A signiﬁcant relationship of nuclear b-catenin expression with ulcerative colorectal cancer was found
(P50.001). However, this ﬁnding was independent of adenomatous polyposis coli tumour suppressor gene mutation and E-
cadherin expression. Together with previous data, we propose that different combinations of genetic alterations may underlie
different morphological types of colorectal cancer. These ﬁndings should be taken into consideration whenever developing a
new genetic diagnosis or therapy for colorectal cancer.
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Colorectal carcinogenesis involves a multistep progression of gen-
etic mutations. Based on the adenoma–carcinoma sequence, much
research has focused on mutation detection; sequential genetic
alterations have been illustrated as a linear process (Fearon and
Vogelstein, 1990; Kinzler and Vogelstein, 1996). Although this
approach represents a well-known paradigm for the sequential
development of cancer driven by the accumulation of genetic
defects, more and more cases of carcinogenesis have been reported
in contrast to the linear and clonal development of cancer (Sedivy et
al, 2000). Recently, a non-linear, chaodynamic model of carcino-
genesis has been suggested by others. In this model, genetic
instability among cells produces a tremendous and chaotic diversity
that may lead to cancer (Coffey, 1998). Furthermore, from a holistic
point of view, not only genetic events may drive the onset of cancer.
In biology, deterministic and non-deterministic phenomena co-
exist. Clinically, in terms of gross morphology, colorectal cancer
(CRC) is not a homogeneous disease entity (Kudo, 1993; Hamilton,
1995; Kato et al, 1997). In general, there are two common but
distinct morphological types, namely polypoid and ulcerative color-
ectal tumours (Hamilton, 1995). These are distinguished by
different gross appearances: either an exophytic or endophytic
growth pattern (Figure 1). Polypoid tumours always show distin-
guished protruding or exophytic growth towards the bowel lumen
(Figure 1A). Ulcerative tumours have an ulcer that usually exhibits
endophytic growth toward the bowel wall itself; thus the tumour’s
ﬂoor may be below the surface of the surrounding mucosa (Figure
1B). These divergent morphological features lead us to question
whether different genetic or different combinations of genetic
alterations are what are involved in colorectal carcinogenesis.
In the model proposed by Vogelstein et al (1988), adenomatous
polyposis coli (APC) tumour suppressor gene mutation is found in
the earliest stage, before proceeding to K-ras mutation as well as to
other tumour suppressor genes, such as p53 and DCC. Paralleling
increases in adenoma size and grade of dysplasia ensue during
colorectal tumour progression. However, nothing has been
described on whether different genetic alterations occurred between
these two distinct types of colorectal cancer during multistep carci-
nogenesis. Although data from synchronous adenoma and
carcinoma analyses emphasised that the accumulation of genetic
alterations is more important than their order (Fearon and Vogel-
stein, 1990; Kinzler and Vogelstein, 1996), some researchers are still
interested in establishing an ideal linear process. Nonetheless, there
are reports indicating that the signiﬁcantly low frequency of K-ras
mutation is associated with superﬁcial or non-polypoid type color-
ectal adenoma or carcinoma (Yamagata et al, 1994, 1995). Others
and we have further demonstrated signiﬁcant correlation between
polypoid growth of CRC and K-ras codon 12 mutation (Chiang
et al, 1998). However, with regard to the ulcerative type of color-
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expression of b-catenin, which plays an important role in the
morphogenesis and carcinogenesis of colorectal cancer (Gumbiner,
1996). Apart from its involvement in cell adhesion and the Wing-
less/Wnt signaling pathway, b-catenin may play a direct role in
colorectal carcinogenesis because it binds the products of the
APC tumour suppressor gene. When APC is mutated, which occurs
in up to 80% of colorectal cancer, b-catenin accumulates and
translocates to the nucleus, where it binds the transcription factors
of the TCF/LEF gene family and activates the expression of target
genes (Korinek et al, 1997).
We attempted to detect if any differential expression of b-cate-
nin was related to different morphological growth patterns in
colorectal carcinomas. Factors related to altered b-catenin expres-
sion including E-cadherin expression, mutations of the APC
tumour suppressor gene or the b-catenin gene itself were also
investigated. Materialising matrix metalloproteinase-7 (MMP-7)
expression, one of the downstream targets of b-catenin, was also
analysed in relation to b-catenin expression.
MATERALS AND METHODS
Sample collection
We collected 51 primary colorectal carcinoma tissue samples from
sporadic colorectal cancer patients who underwent colectomies at
Chang Gung Memorial Hospital (CGMH). All samples were
collected immediately after resection and stored in a 7808C free-
zer. Normal mucosa samples were removed at the same time from
sites about 10 cm from each tumour. Whole tumour specimens
were then prepared for routine histopathological examination.
Formalin-ﬁxed, parafﬁn-embedded colorectal carcinoma tissue
samples were preserved in the tissue archives of the Pathology
Department at CGMH.
Detailed morphological descriptions, histopathological data and
clinical data were obtained for each case from the Cancer Registry
of the Department of Colorectal Surgery at CGMH.
Tumours with exophytic cauliﬂower-like appearances with or
without a very shallow ulcer only, and with a height exceeding half
their diameter, were classiﬁed as polypoid (Figure 1A). Tumours
within depressed ulcers with or without very low elevated edges,
and showing endophytic growth, were classiﬁed as ulcerative
(Figure 1B).
Immunohistochemistry
Standard immunohistochemical detection with minor modiﬁca-
tions was performed on sections from the archival, parafﬁn-
embedded tissue to detect E-cadherin, b-catenin and matrilysin
proteins.
Five-micron sections mounted onto slides were deparafﬁnised
and rehydrated in graded alcohols and distilled water. Endogenous
peroxidase activity was inhibited by incubation with 3% hydrogen
peroxide in methanol for 20 min. Antigen retrieval was done by
microwaving at high power for two cycles of 5 min each, with a
10-min break between cycles in citrate buffer at pH 6.0. Non-speci-
ﬁc binding of secondary antibodies was blocked by incubation in
10% normal rabbit serum.
Incubations with primary antibodies were done at 378C for
120 min for anti E-cadherin (Transduction Laboratories, Lexing-
ton, KY, USA) at 1006 dilution, 60 min at 378C for anti-b-
catenin (Transduction Laboratories) at 2006 dilution and
1:300 for MMP-7 (Chemicon, Hofhem, Germany). After three
washes with phosphate buffered saline (PBS), the slides were
incubated with biotinylated antimouse immunoglobulin and
stained using the Ultra Tech Detection System Kit (Immuno-
tech, Cedex, France). 3,3' Diaminobenzidine (DAB) was used
as the chromogen. The slides were counterstained with hema-
toxylin and dehydrated in graded alcohols, air-dried and
mounted using a resin-based mounting medium (Immunotech)
under coverslips.
Stain interpretation
Slides were independently examined by two experienced observers
(JM Chiang and KF Ng) who were blind to the clinicopathologi-
cal data of the tumour and to the initial results of the other
observer. In areas of well-preserved tissue, the staining intensity
of the cell membrane or cytoplasm was evaluated using the stain-
ing of adjacent non-involved normal mucosa as the internal
control for each section. Membrane expression of E-cadherin or
b-catenin was considered preserved when staining of cancer cells
was as strong as that of normal glands, and the proportion of
positive cancer cells in each section was more than 90%. If there
was identiﬁable positive staining in less than 10% of the cancer
cells, the tumours were recorded as having a loss of E-cadherin
or b-catenin membrane expression. Nuclear staining of positive
cells was deﬁned as an intense brown colour in the nucleus
(Figure 2). The pattern of nuclear staining was deﬁned as follows:
negative group, no less than 5% scattered positive cells without
any clusters; focal group, positive cells clustered in focal areas,
when 45%, but 550% of the nuclei were stained; diffuse,
over-expressed group, positive cells distributed diffusely, homoge-
neously or heterogeneously, when 550% of the nuclei were
stained.
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Figure 1 (A) polypoid tumour; (B) ulcerative tumour.
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Genomic DNA from each tumour sample and corresponding
normal mucosa was extracted. SSCP analysis of b-catenin exon 3
was performed using the following primer pair: exon 3, 5'-GATTT-
GATGGAGTTGGACATGG-3' and 5'-TGTTCTTGAGTGAAGGAC-
TGAG-3'. Samples were ampliﬁed through 35 cycles on a thermo-
cycler (Perkin-Elmer) at 958C denaturation for 50 s, 578C
annealing for 30 s and 728C extension for 10 min. Polymerase
chain reaction (PCR) was performed in a volume of 25 ml with
20 ng of genomic DNA in a PCR buffer containing 1.5 mM MgCl2,
200 mM each deoxyribonucleoside triphosphate, 5 pmol of each
primer and 0.5 units of Taq polymerase (Perkin-Elmer, Branch-
burg, NJ, USA).
For the investigation of the APC gene, exon 15 mutations were
performed using the protein truncation test (PTT) on genomic
DNA as described previously (Van der Luijt, 1994). Exons 1–14
were screened by SSCP using published oligonucleotides and
PCR conditions (Van der Luijt, 1994; Li et al, 1999). After PCR
ampliﬁcation, products were loaded onto 12.5% polyacrylamide
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Figure 2 Representative immunohistochemical staining of E-cadherin and b-catenin in resected colon specimens from sporadic CRC: (A) E-cadherin and
(C) b-catenin are mainly localised at the membranes of the cell-to-cell borders (preserved, parafﬁn-embedded colorectal carcinoma); (B) loss of membrane
staining for E-cadherin. Both (D) and (E) show a loss of membrane staining of b-catenin with reciprocal change in nuclear b-catenin expression. (D) Diffuse,
widespread nuclear immunostaining for b-catenin is profound in colon carcinoma cells, while (E) shows focal, clustered nuclear b-catenin expression. A–E:
6400.
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Uppsala, Sweden) and underwent electrophoresis at 208C. The
single and double strands of the PCR products were visualised
by silver staining as described previously.
Statistics
Comparative data were analysed using the Mann–Whitney U-test,
the Pearson’s correlation coefﬁcient and the chi-square test. A two-
sided P50.05 was determined as statistically signiﬁcant.
RESULTS
We collected 51 colorectal carcinoma samples, including 25
ulcerative tumours and 26 polypoid tumours. The clinicopatholo-
gical parameters, including age, gender, tumour stage, tumour
differentiation and tumour size were comparable between the
two groups, except for right colon predominance in the polypoid
CRC group and signiﬁcantly deeper invasion depth in the ulcera-
tive CRC group (Table 1). The difference in depth of invasion
between these two groups were mainly reﬂected in the smaller-
sized (44 cm) tumour group, while no difference in invasion
depth was found for the larger-sized (44 cm) tumour group
(Table 2).
Regarding b-catenin and E-cadherin expression by immunohis-
tochemical staining, loss of membrane staining was observed in
23 out of the 51 (45%) and 22 out of the 51 (43%) cases,
respectively. Forty-nine per cent (25 out of 51) of cases showed
nuclear b-catenin expression and always showed a reciprocal loss
of membrane staining except for two preserved cases (Table 3).
There was no signiﬁcantly different expression of E-cadherin
found between polypoid and ulcerative groups. However, a
signiﬁcant difference in membrane b-catenin staining was found
between ulcerative (17 out of 25, 68%) and polypoid (six out of
26, 23%) groups. A signiﬁcant difference in nuclear expression of
b-catenin (P=0.001) was also observed between the ulcerative (18
out of 25, 72%) and polypoid (seven out of 26) groups of CRC
(Table 3) when we deﬁned more than 25% of cells with nuclear
b-catenin expression as positive, and negative was deﬁned as
expression in less than 25% of the cells. Nonetheless, nuclear
b-catenin expression was typically heterogenous; we, therefore,
analysed the extent of nuclear b-catenin expression with relation
to these two distinct morphological types of CRC. We found a
signiﬁcant difference between polypoid and ulcerative types of
CRC. However, we did not ﬁnd a signiﬁcant difference related
to the depth of invasion or the location of the tumour (Table
4).
The frequency of APC mutations was 39 out of 51 (76%) cases.
Among the 39 mutations found, 34 were detected in exon 15 trun-
cated proteins (Figure 3), two mutations were found in exon 12,
one in exon 10 and one in exon 6. Nineteen out of 25 (76%)
APC mutations were found in polypoid tumours and 20 out of
26 (77%) were found in ulcerative tumours (Table 3). No b-cate-
nin exon 3 mutation was detected in this study.
Nuclear b-catenin expression was analysed in relation to its
related factors. There were no correlations found among nuclear
b-catenin expression and APC gene mutations (Table 5). In addi-
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Table 1 Comparisons of clinical and histopathological parameters be-
tween ulcerative and polypoid colorectal carcinomas
Ulcerative Polypoid
(n=25) (n=26) P value
Age range (years) 41–83 29–80
Average age (years) 61.3 60.6 0.752
Sex
M/F 17/8 14/12 0.301
Tumour location
Right colon 1 4
Left colon 4 12
Rectum 20 10 0.010
Duke’s stage
A0 4
B1 4 1 3
C9 6
D 2 3 0.186
Depth of invasion
a
T1 1 8
T2 19 17
T3 5 1 0.017
Tumour differentiation
Well 5 9
Moderate 20 15
Poorly 0 2 0.147
Tumour histology
Adenocarcinoma 22 21
Mucinous adenocarcinoma 3 5 0.457
Tumour size
53c m 7 5
3–5 cm 12 16
45 cm 6 5 0.614
aT1: Tumour invades submucosa; T2: Tumour invades muscularis propria; T3:
Tumour invades through the muscularis propria into the subserosa.
Table 2 Comparisons of invasion depth between polypoid and ulcera-
tive colorectal cancer
Polypoid Ulcerative P value
Tumour size 44c m
T1 6 1
T2 5 10
T3 0 3 0.018
Tumour size 44c m
T1 2 0
T2 12 9
T3 1 2 0.333
Table 3 Comparisons of APC mutation and expression of b-catenin and
E-cadherin between ulcerative and polypoid colorectal carcinoma
Ulcerative Polypoid
(n=25) (n=26) P value
Nuclear b-catenin expression
a
+1 8 7
7 7 19 0.001
Membranous b-catenin expression
b
+8 2 0
7 17 6 0.001
Membranous E-cadherin expression
c
+1 5 1 4
7 10 12 0.626
APC mutation
+1 9 2 0
7 6 6 0.843
b-catenin exon 3 mutation
+0 0
7 25 26
aNuclear b-catenin expression was deﬁned as positive (+) whenever more than 25%
of the cells showed nuclear b-catenin expression.
bNuclear b-catenin expression was
reciprocal with the loss of membrane b-catenin expression, except in two cases
showing preserved (+) membrane staining.
c+ means preserved, 7 means loss of
membrane staining.
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nuclear b-catenin expression. Twenty-two per cent (11 out of 51)
of the cases demonstrated positive matrilysin (MMP-7) staining,
and were observed in all eight mucinous colorectal carcinomas,
one in poorly differentiated CRC and the other two in well differ-
entiated CRC. Nonetheless, of these 11 cases, only three
demonstrated nuclear b-catenin expression.
DISCUSSION
We clearly demonstrated that nuclear b-catenin expression was
signiﬁcantly related to ulcerative growth of CRC. This result is
comparable to results in a recent report (Aust et al, 2001) describ-
ing altered distribution of b-catenin in ulcerative colitis-related
colorectal cancer.
Morphologically, the gross appearance of advanced sporadic
CRC is quite variable. It is usually difﬁcult to categorise all
tumours into either the polypoid or ulcerative groups because
intermediate or mixed types showing variable amounts of both
components can be found. Other less frequently encountered types
are ﬂat or plateau tumours or the rare pipe-like shaped (linitis
plastica) tumours. This striking diversity in the gross appearance
of CRC may reﬂect the underlying chaotic genetic instability. In
our study, we investigated purely polypoid and purely ulcerative
tumours. The implications of our ﬁndings are further discussed
below.
Contradictory to previous studies showing that K-ras codon 12
mutation is selectively related to polypoidal growth of CRC (Yama-
gata et al, 1994; Chiang et al, 1998), our study indicated that there
were different combinations of genetic alterations occurring in
morphologically different tumours during colorectal carcinogenesis.
Therefore, reports trying to deﬁne the sequence or the speciﬁc sites
of genetic alterations during multi-step colorectal carcinogenesis
should be very carefully considered because the same combinations
of genetic alterations may not always be accumulated among the
morphological types of CRC. Our ﬁndings highlight that future
development of responsible genes for gene therapy or genetic diag-
nosis for CRC may need to be individualised.
Although many in vitro studies using cell lines have proven that
mutations in the APC tumour suppressor gene occurs in most
colorectal cancer and leads to the activation of b-catenin (Mune-
mitsu et al, 1995; Morin et al, 1997), this probably is not always
the case in vivo. In our study, we showed that nuclear b-catenin
expression was independent of APC tumour suppressor gene muta-
tion, as was reported previously (Kobayashi et al, 2000).
Furthermore, we did not ﬁnd any b-catenin mutation itself. The
question follows, therefore, what regulates or forces the nuclear
translocation of b-catenin? Other genetic or epigenetic events
may be present for modulating nuclear translocation. Tyrosine
phosphorylation of b-catenin by a biochemical molecule such as
intestinal trefoil factor has been reported (Liu et al, 1997). While,
retinoic acid (RA) has been shown to decrease the activity of the b-
catenin- lymphoid enhancer binding factor/T-cell factor signalling
pathway. RA activity was also independent of APC tumour
suppression and ubiquitination-dependent degradation of cytoplas-
mic b-catenin (Easwaran et al, 1999).
Although a signiﬁcant relationship exists between ulcerative
CRC and nuclear b-catenin expression, we did not ﬁnd a signiﬁ-
cant increase in the extent of nuclear b-catenin expression
related to the depth of invasion (Table 4). These ﬁndings indicate
that although nuclear b-catenin expression may determine the
ulcerative growth pattern of CRC, the depth of invasion may be
determined by several other factors, and might be the result of a
more complex process between tumour and stroma interaction.
This ﬁnding also implies that higher amounts of nuclear b-catenin
expression are probably necessary for the ulcerative growth from
the early stage of tumour progression, while lower amounts of
nuclear b-catenin expression may be sufﬁcient to induce polypoid
tumour growth (Brabletz et al, 2000). This ﬁnding supports a
previous observation showing that b-catenin occurred in the high-
est concentrations in the invading line of endophytic growth of
tumour cells. (Brabletz et al, 1998). Although we found a signiﬁ-
cant correlation between nuclear beta-catenin expression and
ulcerative growth and also observed that most of the ulcerative
tumours were rectal carcinomas (Table 1), we did not observe a
signiﬁcant relationship between tumour localisation and nuclear
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Table 4 Relationship between nuclear expression of b-catenin and his-
topathology of colorectal cancers
Nuclear b-catenin expression
Negative
Focal
Diffuse
55% 5–24% 25–49% 550% P value
Gross morphology
Polypoid 7 12 7 0
Ulcerative 2 5 11 7 0.001
Depth of invasion
T1 2 4 3 0
T2 7 11 13 5
T3 0 2 2 2 0.607
Tumour location
Right colon 1 1 2 1
Left colon 1 7 8 0
Rectum 7 9 8 6 0.490
Figure 3 Protein truncation test for APC. Each lane represents the in vi-
tro protein synthesis results of patients with sporadic colon cancer. Note
that in several patients extra bands can be seen due to varied sized trun-
cated protein. Size-fractionated on a 10% SDS-polyacrylamide gel. Lane
M is luciferase as molecular weight marker. Size marker (right) is in kilodal-
tons (kd).
Table 5 Correlation between nuclear b-catenin expression and APC
mutation, E-cadherin expression and MMP-7 expression
Nuclear b-catenin expression
+ 7 7 P value
APC
+1 7 1 7
7 8 9 0.483
E-cadherin expression
+1 5 1 4
7 11 11 0.848
MMP-7 expression
+3 8
7 22 18 0.103
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this study limited further analysis of whether there are different
carcinogenesis pathways in the colon and rectum.
Precisely how nuclear b-catenin expression confers ulcerative or
endophytic growth to CRC remains poorly understood. Further
analyses of several downstream factors of the nuclear b-catenin/
TCF complex, including c-MYC (He et al, 1998), cyclin D1 (Tetsu
and McCormick, 1999), gastrin (Koh et al, 2000), PPARS (He et al,
1999) MMP-7 (Brabletz et al, 1999; Crawford et al, 1999) are
warranted. Some factors such as c-myc, cyclin D and gastrin
reportedly relate to tumour proliferation, while others are related
to tumour invasion. MMP-7 is regulated by b-catenin expression
(Brabletz et al, 1999) and is a proteolytic enzyme related to tumour
invasion. It may well be reasonable to relate proteolysis to ulcera-
tive growth. However, in our study, we did not observe parallel
expression between b-catenin and MMP-7, which is the case in cell
culture studies. These negative ﬁndings may be explained similarly
to other down-regulators such as tumour growth factor (TGF)-b,
which is involved in a more complex process in vivo than in vitro
(Gaire et al, 1994).
Finally, the ﬁnding that nuclear b-catenin expression is closely
related to ulcerative growth of CRC further supports a previous
study that showed analogies between embryonic gastrulation and
b-catenin expression (Kirchner and Brabletz, 2000). Strong, diffuse
b-catenin nuclear expression was observed as necessary for
mesenchymal transition of tumour cells that expressed invasion
behaviour, while weak nuclear b-catenin expression was only
enough for epithelial transitions responsible for cell proliferation
(Kirchner and Brabletz, 2000). The connection of our data and
the data from embryonic development, thus, supports the concept
that tumorigenesis has the properties of a complex developmental
disorder (Dean, 1998).
In summary, we observed that the different combinations of
genetic alterations may selectively underlie different types of
CRC. Nuclear b-catenin expression is related to the ulcerative
growth patterns of CRC. Although the precise mechanism remains
poorly understood, its expression is independent of APC mutation.
These observations further highlight the heterogenous nature of
CRC, which should be kept in mind when developing a new gene
therapy or a new genetic diagnosis for CRC.
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